According to the research report titled ‘Global Extra Corporeal Membrane Oxygenation (Ecmo) System Market 2019-2028’, available with Market Study Report, global extracorporeal membrane oxygenation (ECMO) system market is expected to register 4.81% CAGR through 2028.
 

Soaring prevalence of chronic diseases such as respiratory and cardiovascular diseases, in consort with increased awareness regarding the technology through government and organizational efforts are catalyzing the growth of global extracorporeal membrane oxygenation (ECMO) system market. Additionally, advancements in technology as well as amplifying product applications are fueling the industry expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552648/
 

Despite the positive aspects, huge cost and risks associated with ECMO systems, inadequately experienced laborers as well as alternative techniques like anti-inflammatory therapy and vaccination for treating cardiopulmonary & respiratory diseases are likely to restrain the growth of the business domain over 2019-2028.
 

Speaking of regional landscape, North America, Europe, Asia Pacific, Middle East & Africa, and Latin America are scrutinized to understand the regional trends in worldwide extracorporeal membrane oxygenation (ECMO) system industry. Among these, North America is anticipated to capture a considerable market share over the analysis timeframe owing to escalating incidences of cardiovascular diseases due to rising prevalence of obesity, high blood pressure, and unhealthy lifestyle, in tandem with prevalence of type-2 diabetes among the population. According to the reports by Centers for Disease Control and Prevention (CDC), cardiovascular disease was the leading cause of death in the United States in 2016.
 

Leading companies influencing global extracorporeal membrane oxygenation (ECMO) system industry trends are Hemovent GmbH, Abbott Laboratories, Getinge, Spectrum Medical Ltd., OriGen Biomedical, Inc., Nipro Corporation, Elsius Biomedical, Inc., ALung Technologies, Inc., LivaNova plc, Medtronic plc, Xenios AG, MicroPort Scientific Corporation, Terumo Medical Corporation, and Eurosets S.r.l. among others.